Pathogenic and Apathogenic Strains of Lymphocytic Choriomeningitis Virus Have Distinct Entry and Innate Immune Activation Pathways.

Autor: Johnson DM; Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, Louisville, KY 94202, USA.; Department of Microbiology and Immunology, University of Louisville Health Sciences Center, Louisville, KY 94202, USA.; Galveston National Laboratory, Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX 77550, USA.; Sandia National Laboratories, Department of Biotechnology & Bioengineering, Livermore, CA 94550, USA., Khakhum N; Galveston National Laboratory, Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX 77550, USA., Wang M; Department of Pharmacology and Toxicology, University of Louisville Health Sciences Center, Louisville, KY 94202, USA., Warner NL; Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, Louisville, KY 94202, USA.; Department of Microbiology and Immunology, University of Louisville Health Sciences Center, Louisville, KY 94202, USA., Jokinen JD; Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, Louisville, KY 94202, USA.; Department of Pharmacology and Toxicology, University of Louisville Health Sciences Center, Louisville, KY 94202, USA., Comer JE; Galveston National Laboratory, Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX 77550, USA., Lukashevich IS; Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, Louisville, KY 94202, USA.; Department of Pharmacology and Toxicology, University of Louisville Health Sciences Center, Louisville, KY 94202, USA.

Publikováno v: Viruses [Viruses] 2024 Apr 19; Vol. 16 (4). Date of Electronic Publication: 2024 Apr 19.

Impact of adverse event reports from marketing authorization holder-sponsored patient support programs on the performance of signal detection in pharmacovigilance.

Autor: Lee I; Department of Pharmacy Systems, Outcomes and Policy, College of Pharmacy, University of Illinois at Chicago , Chicago, IL, USA., Lee TA; Department of Pharmacy Systems, Outcomes and Policy, College of Pharmacy, University of Illinois at Chicago , Chicago, IL, USA.; Center for Pharmacoepidemiology and Pharmacoeconomics Research, University of Illinois at Chicago , Chicago, IL, USA., Crawford SY; Department of Pharmacy Systems, Outcomes and Policy, College of Pharmacy, University of Illinois at Chicago , Chicago, IL, USA.; Center for Pharmacoepidemiology and Pharmacoeconomics Research, University of Illinois at Chicago , Chicago, IL, USA., Kilpatrick RD; AbbVie, Inc ., North Chicago, IL, USA., Calip GS; Department of Pharmacy Systems, Outcomes and Policy, College of Pharmacy, University of Illinois at Chicago , Chicago, IL, USA.; Center for Pharmacoepidemiology and Pharmacoeconomics Research, University of Illinois at Chicago , Chicago, IL, USA.; Flatiron Health, Inc., New York, NY., Jokinen JD; Department of Pharmacy Systems, Outcomes and Policy, College of Pharmacy, University of Illinois at Chicago , Chicago, IL, USA.; Bristol-Myers Squibb Company, New York, NY.

Publikováno v: Expert opinion on drug safety [Expert Opin Drug Saf] 2020 Oct; Vol. 19 (10), pp. 1357-1366. Date of Electronic Publication: 2020 Jul 27.

Advanced Safety and Genetic Stability in Mice of a Novel DNA-Launched Venezuelan Equine Encephalitis Virus Vaccine with Rearranged Structural Genes.

Autor: Johnson DM; Department of Microbiology and Immunology, School of Medicine, University of Louisville, Louisville, KY 40202, USA.; Center for Predictive Medicine, School of Medicine, University of Louisville, Louisville, KY 40202, USA., Sokoloski KJ; Department of Microbiology and Immunology, School of Medicine, University of Louisville, Louisville, KY 40202, USA.; Center for Predictive Medicine, School of Medicine, University of Louisville, Louisville, KY 40202, USA., Jokinen JD; Department of Pharmacology and Toxicology, School of Medicine, University of Louisville, Louisville, KY 40202, USA., Pfeffer TL; Center for Predictive Medicine, School of Medicine, University of Louisville, Louisville, KY 40202, USA.; Department of Pharmacology and Toxicology, School of Medicine, University of Louisville, Louisville, KY 40202, USA., Chu YK; Center for Predictive Medicine, School of Medicine, University of Louisville, Louisville, KY 40202, USA., Adcock RS; Center for Predictive Medicine, School of Medicine, University of Louisville, Louisville, KY 40202, USA., Chung D; Department of Microbiology and Immunology, School of Medicine, University of Louisville, Louisville, KY 40202, USA.; Center for Predictive Medicine, School of Medicine, University of Louisville, Louisville, KY 40202, USA., Tretyakova I; Medigen, Inc., Frederick, MD 21701, USA., Pushko P; Medigen, Inc., Frederick, MD 21701, USA., Lukashevich IS; Center for Predictive Medicine, School of Medicine, University of Louisville, Louisville, KY 40202, USA.; Department of Pharmacology and Toxicology, School of Medicine, University of Louisville, Louisville, KY 40202, USA.

Publikováno v: Vaccines [Vaccines (Basel)] 2020 Mar 02; Vol. 8 (1). Date of Electronic Publication: 2020 Mar 02.

Novel DNA-launched Venezuelan equine encephalitis virus vaccine with rearranged genome.

Autor: Tretyakova I; Medigen, Inc., 8420 Gas House Pike, Suite S, Frederick, MD 21701, USA., Tibbens A; Medigen, Inc., 8420 Gas House Pike, Suite S, Frederick, MD 21701, USA., Jokinen JD; University of Louisville, 505 S Hancock St., Louisville, KY 40202, USA., Johnson DM; University of Louisville, 505 S Hancock St., Louisville, KY 40202, USA., Lukashevich IS; University of Louisville, 505 S Hancock St., Louisville, KY 40202, USA., Pushko P; Medigen, Inc., 8420 Gas House Pike, Suite S, Frederick, MD 21701, USA. Electronic address: ppushko@medigen-usa.com.

Publikováno v: Vaccine [Vaccine] 2019 May 31; Vol. 37 (25), pp. 3317-3325. Date of Electronic Publication: 2019 May 06.

An Alternative to Disproportionality: A Frequency-Based Method for Pharmacovigilance Data Mining.

Autor: Jokinen JD; 1 Abbvie, Inc, North Chicago, IL, USA., Lievano F; 1 Abbvie, Inc, North Chicago, IL, USA., Scarazzini L; 1 Abbvie, Inc, North Chicago, IL, USA., Truffa M; 1 Abbvie, Inc, North Chicago, IL, USA.

Publikováno v: Therapeutic innovation & regulatory science [Ther Innov Regul Sci] 2018 May; Vol. 52 (3), pp. 294-299. Date of Electronic Publication: 2017 Sep 08.